ClinicalTrials.gg
Drug

Glucuronyl glucosamine glycan sulfate clinical trials

Also written Sulodexide, KRX-101 and vessel due f.

studies test it
17
open now
3
in phase 3
9
first study started
2005

How each study uses glucuronyl glucosamine glycan sulfate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the glucuronyl glucosamine glycan sulfate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vessel
3

Brand

vessel due f
2

Development codes

KRX-101
3

Other names

Sulodexide
16

Studies by the year they started

17 studies that test it; most in 2005 (2)

Studies that test glucuronyl glucosamine glycan sulfate, by start year
YearStudies
20052
20072
20092
20141
20151
20171
20191
20202
20211
20221
20232
20251

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3
Phase 3
9
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 12

Keryx Biopharmaceuticals (3) · Centro Medico del Noroeste (1) · Clinedem (1) · St Joseph University, Beirut, Lebanon (1) · Ajou University School of Medicine (1) · Xijing Hospital (1) · Arianna Anticoagulazione Foundation (1) · Value Outcomes Ltd. (1)

Often tested with

Tested in the same studies.

Linagliptin (1) · Empagliflozin (1) · Telmisartan (1)

Studies

Open first, then newest update. How each study uses glucuronyl glucosamine glycan sulfate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Codes

What other systems call glucuronyl glucosamine glycan sulfate · ClinicalTrials.gg INT002410

  • MeSH (NLM) C007858glucuronyl glucosamine glycan sulfateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 75HGV0062CSULODEXIDEConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.